correlational
Analysis v1
62
0
Whether HIV patients had hepatitis or not didn't change the link between losing visceral fat and improving liver enzymes.
Scientific Claim
The association between VAT reduction and improved liver enzymes in HIV-infected patients with abdominal obesity was not significantly affected by viral hepatitis status.
Original Statement
“The relationship between responder status and change in ALT or AST among tesamorelin-treated patients was not modified by viral hepatitis status.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The claim accurately describes the lack of interaction effect without implying causation, consistent with the study's analysis.
Evidence from Studies
Supporting (1)
62
62
Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV
Randomized Controlled Trial
Human
2017 Oct 23Contradicting (0)
0
No contradicting evidence found